Revmed.com

  1. Home
  2. Revmed.com

Revolution Medicines

WEBWe are Revolutionaries – passionate in our singular pursuit of discovering, developing and delivering novel, targeted medicines for patients living with cancer.

Actived: 3 days ago

URL: https://www.revmed.com/

Revolution Medicines Reports New Application of Tri-Complex …

WEB“We believe this cooperative approach will facilitate effective partnerships with the broader scientific community to speed discoveries that may be impactful in this public health …

Category:  Health Go Health

Revolution Medicines Completes Acquisition of EQRx

WEBMTS Health Partners, L.P. also acted as financial advisor to EQRx. Goodwin Procter LLP acted as legal counsel for EQRx. About Revolution Medicines, Inc. Revolution Medicines …

Category:  Medicine Go Health

Investor Relations Revolution Medicines

WEBCorporate Profile. Revolution Medicines is a clinical-stage oncology company developing novel targeted therapies for RAS-addicted cancers. The company’s R&D pipeline …

Category:  Cancer,  Medicine Go Health

Preliminary Safety and Pharmacokinetic Profiles of RMC-6236, …

WEBRMC-6236 is a novel, oral, non-covalent, RASMULTI(ON) inhibitor that is selective for the active, GTP-bound or ON state of both mutant and wild-type variants of the canonical …

Category:  Health Go Health

Revolution Medicines to Participate in Cowen 42nd Annual Health …

WEBREDWOOD CITY, Calif., March 01, 2022 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing novel targeted …

Category:  Medicine Go Health

First-in-Human Phase 1/1b Trial of the First-in-Class Bi-Steric …

WEBC3D1 determined by Guardant Health molecular response algorithm. Molecular response is ≥50% reduction. –100 –50 0 50 100 Best % Change from Baseline in Target Lesion a C …

Category:  Health Go Health

Revolution Medicines to Participate in 4th Annual Evercore ISI

WEBREDWOOD CITY, Calif., Nov. 24, 2021 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage precision oncology company focused on developing …

Category:  Medicine Go Health

Revolution Medicines Reports Second Quarter 2022 Financial …

WEBLorence Kim, M.D. is an accomplished healthcare industry leader who has made significant contributions across the biotechnology and financial industries during his career at …

Category:  Health Go Health

Revolution Medicines Appoints Lorence Kim, M.D., Accomplished …

WEBBoard composition evolves as company’s development pipeline matures. REDWOOD CITY, Calif., July 13, 2022 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: …

Category:  Medicine Go Health

Sanofi and REVOLUTION Medicines Launch Global Partnership to …

WEBSanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with …

Category:  Health Go Health

Preliminary Safety and Pharmacokinetic Profiles of RMC-6236, …

WEBthe interquartile range; KRASG12XVAF at Cycle 1 Day 1 (pre-treatment) to Cycle 2 Day 1 or Cycle 3 Day 1 (on-treatment) determined by Guardant Health ctDNA test. ctDNA, …

Category:  Health Go Health

Third Rock Ventures Launches REVOLUTION Medicines with $45 …

WEBVideo: Dr. Marty Burke’s research described at the 109 th Meeting of the Advisory Committee to the Francis Collins, M.D., Ph.D., director of the National Institutes of …

Category:  Health Go Health

Revolution Medicines Reports First Quarter 2020 Financial Results …

WEB“We acknowledge the severe health and economic impact of the COVID-19 pandemic we are all experiencing and the burden it has placed on our healthcare system and the …

Category:  Health Go Health

Preliminary Safety and Anti-Tumor Activity of RMC-6291, a …

WEBKRASG12C occurs in ~13% of non-small cell lung cancer and ~3–4% of colorectal cancer. Currently approved KRASG12C inhibitors target the inactive, GDP-bound or OFF state …

Category:  Cancer Go Health

Revolution Medicines to Participate in Upcoming Investor …

WEBREDWOOD CITY, Calif., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for …

Category:  Medicine Go Health

Revolution Medicines Strengthens Senior Management Team with …

WEBSimon joins Revolution Medicines from Guardant Health where he most recently served as the company’s senior vice president, biopharma business development. During his …

Category:  Medicine Go Health

Preliminary Safety and Anti-Tumor Activity of RMC-6291, a …

WEBKRASG12CVAF at Cycle 1 Day 1 (pre-treatment) to Cycle 2 Day 1 or Cycle 3 Day 1 (on-treatment) determined by Guardant Health ctDNA(circulating tumorDNA) test. ctDNA, …

Category:  Health Go Health

TD Cowen 44th Annual Health Care Conference Revolution …

WEBTD Cowen 44th Annual Health Care Conference. March 6, 2024 2:10 PM EST.

Category:  Health Go Health

Top Categories

 › Appendicitis

 › Headaches

 › Gout

 › Women's Health

 › Thyroid

 › Sleep

 › Skin

 › Sexual Health

 › Senior Health

 › Pregnancy

 › Oral Health

 › Neurology

 › Migraine

 › Mental Health

 › Men's Health

 › Menopause

 › Medications

 › Lung Conditions

 › Infectious Disease

 › HIV/AIDS

Popular Searched

 › Florida life health variable annuity manual

 › Henry ford employee health center

 › University health network hemodialysis team

 › Oxford nature and public health

 › Associate of health science jobs

 › Allied health insurance prior authorization

 › Shifts in health care system

 › 4 factors of mental health

 › Esg reporting in healthcare

 › Perinatal mental health psychopharmacology

Recently Searched

 › Zoo health club membership

 › Norton health care louisville ky women

 › Dr gladys public health

 › Nepal health service act 2053 pdf

 › Health check up in japan

 › Sales mental health examples

 › Global kidney health atlas download

 › Cdc healthcare worker guidance covid

 › Healthy eating cut and paste worksheets

 › Zoo health club reviews